Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;4(1):51-69.
doi: 10.1159/000367728.

Hong Kong consensus recommendations on the management of hepatocellular carcinoma

Ronnie Tung-Ping Poon  1 , Tom Tan-To Cheung  1 , Philip Chong-Hei Kwok  2 , Ann-Shing Lee  3 , Tat-Wing Li  4 , Kwok-Loon Loke  5 , Stephen Lam Chan  6 , Moon-Tong Cheung  7 , Tak-Wing Lai  8 , Chin-Cheung Cheung  9 , Foon-Yiu Cheung  10 , Ching-Kong Loo  11 , Yiu-Kuen But  12 , Shing-Jih Hsu  12 , Simon Chun-Ho Yu  13 , Thomas Yau  12
Affiliations
Review

Hong Kong consensus recommendations on the management of hepatocellular carcinoma

Ronnie Tung-Ping Poon et al. Liver Cancer. 2015 Mar.

Abstract

Background: Hepatocellular carcinoma (HCC) is particularly prevalent in Hong Kong because of the high prevalence of chronic hepatitis B (CHB) infection; HCC is the fourth commonest cancer in men and the seventh commonest in women, and it is the third leading cause of cancer death in Hong Kong. The full spectrum of treatment modalities for HCC is available locally; however, there is currently no local consensus document detailing how these modalities should be used.

Summary: In a series of meetings held between May and October 2013, a multidisciplinary group of Hong Kong clinicians - liver surgeons, medical oncologists, clinical oncologists, hepatologists, and interventional radiologists - convened to formulate local recommendations on HCC management. These recommendations consolidate the most current evidence pertaining to HCC treatment modalities, together with the latest thinking of practicing clinicians engaged in HCC management, and give detailed guidance on how to deploy these modalities effectively for patients in various disease stages.

Key messages: Distinct from other regional guidelines, these recommendations provide guidance on the use of antiviral therapy to reduce the incidence of HCC in CHB patients with cirrhosis and to reduce recurrence of CHB-related HCC.

Keywords: Consensus; Hepatocellular carcinoma; Hong Kong.

PubMed Disclaimer

References

    1. World Cancer Research Fund International. Liver cancer. Available at http://www.wcrf.org/cancer_statistics/data_specific_cancers/liver_cancer.... [Accessed 25 September 2013].
    1. Hong KC. Top Ten Cancers in 2010. [Accessed 25 September 2013];Available at http://www3.ha.org.hk/cancereg/statistics.html.
    1. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74. - PubMed
    1. Burak KW, Kneteman NM. An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm. Can J Gastroenterol. 2010;24:643–650. - PMC - PubMed
    1. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439–474. - PMC - PubMed

LinkOut - more resources